Call +44 (0)1904 798634 or +44 (0)7550 079918

Leading provider of life science market reports and research services

Items 31 to 40 of 46 total

Set Ascending Direction
per page

After the major patent crashes of 2012, last year was more of a transitional period. Johnson & Johnson, Novartis, Roche, GlaxoSmithKline, Eli Lilly and Bayer saw their revenues rise, although only J&J...

Read More
Comments | Posted in Articles By Claire Nicholson

Celgene Corporation has entered into a global license agreement with Nogra Pharma Limited, a private pharmaceutical company based in Dublin, Ireland, to develop and commercialize GED-0301, an oral ant...

Read More
Comments | Posted By Claire Nicholson

Sun Pharmaceutical Industries Ltd. (SUNP), India’s largest drugmaker by market value, agreed to buy Ranbaxy Laboratories Ltd. (RBXY) for $3.2 billion in stock, the biggest purchase by an Indian compan...

Read More
Comments | Posted By Claire Nicholson

Anglo-Swedish drug major AstraZeneca’s IMED Biotech unit has launched a dedicated web site to support an increasing range of open innovation programs and to better facilitate research collaborations w...

Read More
Comments | Posted By Claire Nicholson

scPharmaceuticals, Inc., a privately held biopharmaceutical company developing transformative pharmaceutical products for subcutaneous delivery, announced today that it has closed a $16.0 million Seri...

Read More
Comments | Posted By Claire Nicholson

A combination treatment from GlaxoSmithKline for melanoma, the deadliest form of skin cancer, has been delayed in Europe after regulators said they needed more information. Britain's biggest drugmaker...

Read More
Comments | Posted By Claire Nicholson

Purchase the report: Emerging Biotech Investment Report - Strategic Trends in Private Equity and Venture Capital Funding

 

The importance of capital, particularly for emerging biotechnology firms, canno...

Read More
Comments | Posted in Articles By Claire Nicholson

Furiex Pharmaceuticals Inc. (FURX), the drug developer whose irritable bowel treatment is moving toward regulatory approval, is working with Bank of America Corp. to find a buyer, people with knowledg...

Read More
Comments | Posted By Claire Nicholson

Are the BRIC countries passé in Big Pharma? Not exactly. Brazil, Russia, India and China aren't the great shining frontiers they used to be, but they're still on most drugmakers' to-do lists.

The lates...

Read More

Tags:

Comments | Posted By Claire Nicholson

 2018, it is estimated that the global pharmaceutical market will be worth more than $1.3 trillion USD. To corner their share of profits, established drug companies have to fight fierce competition fr...

Read More
Comments | Posted in Articles By Claire Nicholson

Items 31 to 40 of 46 total

Set Ascending Direction
per page